These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2755487)

  • 21. Spiramycin- and tylosin-resistant strains of Mycoplasma gallisepticum isolated from breeding chickens and pipped eggs.
    Kuniyasu C; Yoshida Y; Takano M
    Natl Inst Anim Health Q (Tokyo); 1974; 14(2):48-53. PubMed ID: 4444733
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of nongonococcal urethritis with ciprofloxacin.
    Fong IW; Linton W; Simbul M; Thorup R; McLaughlin B; Rahm V; Quinn PA
    Am J Med; 1987 Apr; 82(4A):311-6. PubMed ID: 3555054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The in vivo drug sensitivity of a causal agent of swine enzootic pneumonia (SEP).
    Takatori I; Omori T; Fujiwara H; Fujikura T; Namioka S
    Natl Inst Anim Health Q (Tokyo); 1967; 7(4):179-86. PubMed ID: 4172383
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibacterial activities of new nitrofuran derivatives on Mycoplasm gallisepticum and Haemophilus gallinarum.
    Ota S; Watanabe S; Kuniyasu C
    Natl Inst Anim Health Q (Tokyo); 1970; 10(1):1-10. PubMed ID: 4191833
    [No Abstract]   [Full Text] [Related]  

  • 25. The minimum inhibitory concentration of tilmicosin and tylosin for mycoplasma gallisepticum and Mycoplasma synoviae and a comparison of their efficacy in the control of Mycoplasma gallisepticum infection in broiler chicks.
    Jordan FT; Horrocks BK
    Avian Dis; 1996; 40(2):326-34. PubMed ID: 8790882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Assessment of the action of antibotics on the causative agent of respiratory mycoplasma infections of chickens].
    Baĭdevliatov AB; Koval'skiĭ EI
    Veterinariia; 1966 Aug; 43(8):28-32. PubMed ID: 5993299
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of resistant mycoplasma infection in immunocompromised patients with a new pleuromutilin antibiotic.
    Heilmann C; Jensen L; Jensen JS; Lundstrom K; Windsor D; Windsor H; Webster D
    J Infect; 2001 Nov; 43(4):234-8. PubMed ID: 11869060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal study on the therapy of Mycoplasma pneumoniae infections with ciprofloxacin on Syrian hamsters.
    Furneri P; Tempera G; Caccamo F; Speciale A; Nicoletti G
    Chemioterapia; 1987 Jun; 6(2 Suppl):181. PubMed ID: 3151338
    [No Abstract]   [Full Text] [Related]  

  • 29. [Relationship between the endocervical mycoplasma infection and spontaneous abortion due to early embryonic death].
    Ye LL; Zhang BY; Cao WL
    Zhonghua Fu Chan Ke Za Zhi; 2004 Feb; 39(2):83-5. PubMed ID: 15059581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro susceptibility of avian mycoplasmas to enrofloxacin, sarafloxacin, tylosin, and oxytetracycline.
    Wang C; Ewing M; Aarabi SY
    Avian Dis; 2001; 45(2):456-60. PubMed ID: 11417828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistence of Mycoplasma hominis after therapy: importance of tetracycline resistance and of coexisting vaginal flora.
    Koutsky LA; Stamm WE; Brunham RC; Stevens CE; Cole B; Hale J; Davick P; Holmes KK
    Sex Transm Dis; 1983; 10(4 Suppl):374-81. PubMed ID: 6229892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and treatment of Mycoplasma-contaminated cell cultures.
    Harlin H; Gajewski TF
    Curr Protoc Microbiol; 2006 Jan; Appendix 3():Appendix 3B. PubMed ID: 18770568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo comparisons of valnemulin, tiamulin, tylosin, enrofloxacin, and lincomycin/spectinomycin against Mycoplasma gallisepticum.
    Jordan FT; Forrester CA; Ripley PH; Burch DG
    Avian Dis; 1998; 42(4):738-45. PubMed ID: 9876842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinolinehydrazones: structure-activity correlations in a new class of anti-mycoplasmal agents.
    Berkoff CE; Craig PN; Gordon BP; Pellerano C
    Arzneimittelforschung; 1973 Jun; 23(6):830-9. PubMed ID: 4740770
    [No Abstract]   [Full Text] [Related]  

  • 35. [Development of fluoroquinolone (ciprofloxacin) resistance in Mycoplasma hominis in the presence of Hela cells].
    Momynaliev KT; Smirnova OV; Ladygina VG; Orlova VF; Akopian TA; Govorun VM
    Genetika; 2002 Jul; 38(7):922-8. PubMed ID: 12174584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mycoplasma pneumoniae infections in children].
    Möller J
    Nord Med; 1971 Jul; 85(26):807-8. PubMed ID: 5557295
    [No Abstract]   [Full Text] [Related]  

  • 37. Guidelines and recommendations for antimicrobial minimum inhibitory concentration (MIC) testing against veterinary mycoplasma species. International Research Programme on Comparative Mycoplasmology.
    Hannan PC
    Vet Res; 2000; 31(4):373-95. PubMed ID: 10958240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biological properties of Ureaplasma urealyticum and Mycoplasma hominis isolated from patients with urethritis. VI. Sensitivity of M. hominis to selected chemotherapeutic agents].
    Jagielski M
    Med Dosw Mikrobiol; 1988; 40(1):38-49. PubMed ID: 3210837
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro susceptibilities to fluoroquinolones in current and archived Mycoplasma gallisepticum and Mycoplasma synoviae isolates from meat-type turkeys.
    Gerchman I; Lysnyansky I; Perk S; Levisohn S
    Vet Microbiol; 2008 Oct; 131(3-4):266-76. PubMed ID: 18534788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of select antibiotics against Mycoplasma pulmonis from rats and mice.
    Gardner MC; Owens DR; Wagner JE
    Lab Anim Sci; 1981 Apr; 31(2):143-5. PubMed ID: 7242011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.